Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 25.05 TWD
Change Today -0.45 / -1.76%
Volume 5.0K
6130 On Other Exchanges
Symbol
Exchange
Taiwan
As of 2:32 AM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

genome international biomedi (6130) Snapshot

Open
26.70
Previous Close
25.50
Day High
26.70
Day Low
25.05
52 Week High
07/31/14 - 44.21
52 Week Low
07/29/15 - 25.05
Market Cap
668.8M
Average Volume 10 Days
14.6K
EPS TTM
1.55
Shares Outstanding
26.7M
EX-Date
07/23/15
P/E TM
16.2x
Dividend
2.00
Dividend Yield
7.98%
Current Stock Chart for GENOME INTERNATIONAL BIOMEDI (6130)

Related News

No related news articles were found.

genome international biomedi (6130) Related Businessweek News

No Related Businessweek News Found

genome international biomedi (6130) Details

Genome International Biomedical Co. Ltd. engages in the wholesale of Chinese medicines, western medicines, medical equipment, slimming products, and cosmetics in Taiwan and Asia. It is also involved in the research, development, production, and sale of wireless communication integrated circuits; and the operation of various beauty salons, as well as offers other services. The company was founded in 1994 and is headquartered in Taipei, Taiwan.

Founded in 1994

genome international biomedi (6130) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

genome international biomedi (6130) Key Developments

Genome International Biomedical Co. Ltd, Annual General Meeting, Jun 29, 2015

Genome International Biomedical Co. Ltd, Annual General Meeting, Jun 29, 2015.

Genome International Biomedical Co. Ltd Auditor Raises 'Going Concern' Doubt

Genome International Biomedical Co. Ltd filed its Annual on Mar 27, 2015 for the period ending Dec 31, 2014. In this report its auditor, Ernst & Young LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Genome International Biomedical Co. Ltd, Annual General Meeting, Jun 25, 2014

Genome International Biomedical Co. Ltd, Annual General Meeting, Jun 25, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
6130:TT 25.05 TWD -0.45

6130 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 6130.
View Industry Companies
 

Industry Analysis

6130

Industry Average

Valuation 6130 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.4x
Price/Book 1.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENOME INTERNATIONAL BIOMEDI, please visit www.genomeib.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.